SUPPORTIVE CARE FOR PEOPLE LIVING WITH OR BEYOND CANCER TREATMENT
Dr Hannah Wardill, Hospital Research Foundation Fellow, University of Adelaide & Head of Supportive Oncology Group (Precision Cancer Medicine)
SAHMRI (South Australian Health and Medical Research Institute)
RESEARCHER PROFILE
Filmed in Adelaide, South Australia | January 2025
Dr Hannah Wardill is a Hospital Research Foundation Fellow and lead of the Supportive Oncology Research Group (SORG), in the School of Biomedicine, University of Adelaide and Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI). She is an Executive Board Member of the Multinational Association for Supportive Care in Cancer / International Society for Oral Oncology (MASCC/ISOO) and Chair of both MASCC/ISOO Patient Partnership Committee & the Palliative Care Clinical Studies Collaborative (PaCCSC) Cancer Symptom Trials (Gut Dysfunction Node; supported by Cancer Australia).
While her research started in understanding how chemotherapy damages gut health, Dr Wardill’s research program has now expanded to include a range of symptoms and side effects including neuropathy, cognitive impairment, infection and malnutrition.
A fierce advocate for supportive cancer care, Dr Wardill is working to improve the visibility of this research area and remind people that optimal cancer control can (and should) involve high quality, evidence-based supportive care to ensure people living with or beyond cancer can live happy and fulfilling lives.
https://orcid.org/0000-0002-6613-3661
-
Development of novel analytical and diagnostic tools using nanotechnology and microfluidics
Dr Alain Wuethrich is an NHMRC Emerging Leader fellow and ARC DECRA awardee at the Australian Institute for Bioengineering and Nanotechnology.
Hailing from Switzerland, research focuses on the development of novel analytical and diagnostic tools that harness nanotechnology and microfluidics; two rapidly growing fields with high potential to provide diagnostic solutions needed for precision medicine.
-
CASE STUDY Next Generation Condom Contraception
Eudaemon Technologies, an early-stage medtech company with a focus on sexual reproductive health, is developing a hydrogel condom to address the need for a better feeling, next generation condom, with the potential to improve user experience and address issues with traditional latex condoms.
“Over 1 million STI’s being diagnosed every day and up to 120 million unplanned pregnancies every year result in a $60 billion health burden across the globe”, says Co-Founder and Executive Director of Operations, Dr Simon Cook.
Formed in 2018, the company focuses on developing tough hydrogels as an alternative to address issues with odour, colour, and taste commonly associated with latex condoms. This technology can be loaded with small molecule drugs for flavours or anti-STI compounds, and was developed in response to a grant from the Bill and Melinda Gates Foundation to address unplanned pregnancies and STIs.
-
Forensic psychiatry research in the setting of the justice system
Prof Kimberlie Dean is Head of the Discipline of Psychiatry and Mental Health at UNSW. She was appointed to the inaugural Chair in Forensic Mental Health at UNSW in 2011, a joint appointment with Justice Health NSW. She also holds a Clinical Academic appointment as a Consultant Forensic Psychiatrist with Justice Health NSW. She is Academic Program Director for the Masters Forensic Mental Health at UNSW.
